悦心健康
(002162)
| 流通市值：41.06亿 | | | 总市值：41.11亿 |
| 流通股本：9.18亿 | | | 总股本：9.20亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 181,924,751.84 | 198,822,175.7 | 270,868,911.2 | 215,355,938.45 |
| 应收票据及应收账款 | 109,560,360.92 | 113,634,131.69 | 139,727,574.7 | 146,940,661.76 |
| 其中：应收票据 | 11,702,177.03 | 8,582,317.65 | 8,105,711.49 | 10,842,951.09 |
| 应收账款 | 97,858,183.89 | 105,051,814.04 | 131,621,863.21 | 136,097,710.67 |
| 应收款项融资 | 364,237.95 | 0 | 0 | 182,992.13 |
| 预付款项 | 31,193,489.13 | 21,529,571.7 | 29,663,196.02 | 38,693,107.34 |
| 其他应收款合计 | 25,315,333.82 | 18,861,922.24 | 21,629,320.07 | 20,973,107.43 |
| 存货 | 130,575,847.22 | 141,638,170.88 | 135,444,328.41 | 151,735,361.43 |
| 一年内到期的非流动资产 | 51,844,333.33 | 51,569,333.34 | 39,332,657.53 | 39,117,335.67 |
| 其他流动资产 | 3,117,357.05 | 2,632,156.88 | 2,441,401.08 | 2,598,194.38 |
| 流动资产合计 | 565,230,439.03 | 580,022,190.2 | 670,307,389.01 | 646,796,698.59 |
| 非流动资产: | | | | |
| 长期股权投资 | 272,690,326.59 | 270,895,666.81 | 244,321,624.68 | 246,422,017.25 |
| 其他非流动金融资产 | 62,681,865 | 62,681,865 | 76,181,865 | 70,181,865 |
| 投资性房地产 | 539,540,800 | 539,540,800 | 537,432,000 | 537,432,000 |
| 固定资产 | 250,093,831.24 | 256,135,431.77 | 267,647,755.35 | 270,352,718.86 |
| 在建工程 | 4,105,535.17 | 3,879,396.9 | 2,493,642.05 | 1,263,448.67 |
| 使用权资产 | 40,589,489.08 | 50,787,788.41 | 33,833,725.56 | 39,657,847.85 |
| 无形资产 | 18,785,784.43 | 17,582,256.8 | 17,876,340.54 | 18,171,557.67 |
| 开发支出 | - | - | 0 | 0 |
| 商誉 | 14,622,222.77 | 0 | 0 | 0 |
| 长期待摊费用 | 55,041,909.25 | 56,866,784.94 | 58,152,616.22 | 29,157,975.26 |
| 递延所得税资产 | 33,135,030.48 | 33,733,770.58 | 31,363,511.06 | 31,363,511.06 |
| 其他非流动资产 | 63,878,836.61 | 67,876,976.03 | 66,189,006.79 | 111,250,390.3 |
| 非流动资产合计 | 1,355,165,630.62 | 1,359,980,737.24 | 1,335,492,087.25 | 1,355,253,331.92 |
| 资产总计 | 1,920,396,069.65 | 1,940,002,927.44 | 2,005,799,476.26 | 2,002,050,030.51 |
| 流动负债: | | | | |
| 短期借款 | 205,406,117.01 | 194,320,089.25 | 245,249,547.23 | 238,178,644.5 |
| 应付票据及应付账款 | 192,541,304.52 | 215,575,429.06 | 244,896,986.17 | 275,919,937.95 |
| 其中：应付票据 | 74,596,684.37 | 89,004,447.6 | 105,522,558.7 | 119,352,052.66 |
| 应付账款 | 117,944,620.15 | 126,570,981.46 | 139,374,427.47 | 156,567,885.29 |
| 合同负债 | 67,434,997.44 | 57,882,105.3 | 65,541,857.88 | 50,965,456.1 |
| 应付职工薪酬 | 23,649,009.27 | 29,480,068.36 | 20,057,879.83 | 19,004,353.87 |
| 应交税费 | 8,907,419.78 | 9,164,998.49 | 9,349,776.92 | 7,835,138.76 |
| 其他应付款合计 | 84,504,859.49 | 83,729,054.32 | 89,616,234.87 | 80,807,996.27 |
| 保险合同准备金 | - | - | 0 | 0 |
| 一年内到期的非流动负债 | 35,162,086.89 | 44,321,818.33 | 38,224,336.54 | 39,293,344.9 |
| 其他流动负债 | 8,111,949.29 | 8,164,354.18 | 10,366,676.73 | 7,047,109.26 |
| 流动负债合计 | 625,863,086.02 | 642,783,259.62 | 723,303,296.17 | 719,051,981.61 |
| 非流动负债: | | | | |
| 长期借款 | 278,161,750 | 281,499,250 | 290,544,500 | 288,880,000 |
| 租赁负债 | 34,290,961.84 | 36,334,086.32 | 18,496,771.28 | 21,876,134.01 |
| 递延收益 | 2,464,712.6 | 2,464,712.6 | 1,978,525.25 | 1,978,525.25 |
| 递延所得税负债 | 137,003,433.07 | 137,003,433.07 | 134,126,963.63 | 134,126,963.63 |
| 其他非流动负债 | 1,664,239.96 | 1,664,239.96 | 1,051,498.26 | 1,051,498.26 |
| 非流动负债合计 | 453,585,097.47 | 458,965,721.95 | 446,198,258.42 | 447,913,121.15 |
| 负债合计 | 1,079,448,183.49 | 1,101,748,981.57 | 1,169,501,554.59 | 1,166,965,102.76 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 919,700,965 | 919,700,965 | 919,700,965 | 919,700,965 |
| 资本公积 | 36,068,437.27 | 36,068,437.27 | 38,149,646.28 | 179,206,875.07 |
| 其他综合收益 | 67,091,716.57 | 67,091,716.57 | 67,091,716.57 | 67,091,716.57 |
| 盈余公积 | 0 | 0 | 0 | 72,853,943.26 |
| 未分配利润 | -206,033,843.49 | -199,935,970.94 | -203,578,731.28 | -418,806,296.41 |
| 归属于母公司股东权益合计 | 816,827,275.35 | 822,925,147.9 | 821,363,596.57 | 820,047,203.49 |
| 少数股东权益 | 24,120,610.81 | 15,328,797.97 | 14,934,325.1 | 15,037,724.26 |
| 股东权益合计 | 840,947,886.16 | 838,253,945.87 | 836,297,921.67 | 835,084,927.75 |
| 负债和股东权益合计 | 1,920,396,069.65 | 1,940,002,927.44 | 2,005,799,476.26 | 2,002,050,030.51 |
| 公告日期 | 2026-04-22 | 2026-03-31 | 2025-10-25 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |